Xpovio 40 mg twice-weekly
Generic name: Selinexor
Drug class:
Miscellaneous antineoplastics
Usage of Xpovio 40 mg twice-weekly
Xpovio 40 mg twice-weekly is used together with bortezomib and/or dexamethasone to treat multiple myeloma in adults.
Xpovio 40 mg twice-weekly is also used in adults to treat certain types of diffuse large B-cell lymphoma.
Xpovio 40 mg twice-weekly is given after other medications did not work or have stopped working.
Xpovio 40 mg twice-weekly was approved by the US Food and Drug Administration (FDA) on an "accelerated" basis. In clinical studies, some people responded to Xpovio 40 mg twice-weekly, but further studies are needed.
Xpovio 40 mg twice-weekly may also be used for purposes not listed in this medication guide.
Xpovio 40 mg twice-weekly side effects
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Xpovio 40 mg twice-weekly can cause serious or fatal side effects. Some side effects may not occur until you have been taking this medicine for several days or weeks.
Xpovio 40 mg twice-weekly may cause serious side effects. Call your doctor at once if you have:
Your treatments may be delayed or permanently discontinued if you have certain side effects.
Common side effects of Xpovio 40 mg twice-weekly may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Xpovio 40 mg twice-weekly
Tell your doctor if you have ever had:
You may need to have a negative pregnancy test before starting this treatment.
Both men and women using Xpovio 40 mg twice-weekly should use effective birth control to prevent pregnancy. Xpovio 40 mg twice-weekly can harm an unborn baby if the mother or father is using this medicine.
Keep using birth control for at least 1 week after your last dose. Tell your doctor right away if a pregnancy occurs while either the mother or the father is using Xpovio 40 mg twice-weekly.
This medicine may affect fertility (ability to have children) in both men and women. However, it is important to use birth control to prevent pregnancy because Xpovio 40 mg twice-weekly can harm an unborn baby.
Do not breastfeed while using this medicine, and for at least 1 week after your last dose.
Not approved for use by anyone younger than 18 years old.
Relate drugs
- Abiraterone
- Abiraterone, micronized
- Adagrasib
- Adstiladrin
- Altretamine
- Amivantamab
- Amivantamab-vmjw
- Arsenic trioxide
- Asparaginase Erwinia chrysanthemi
- Asparaginase erwinia chrysanthemi recombinant-rywn
- Asparlas
- Axicabtagene ciloleucel
- Azacitidine
- Azacitidine (Injection)
- Azacitidine (Oral)
- Abecma
- Bacillus of calmette and guerin vaccine, live (Intradermal)
- Bacillus of calmette and guerin vaccine, live (Intravesical)
- BCG intravesical
- Belantamab mafodotin
- Belantamab mafodotin-blmf
- Belzutifan
- Besponsa
- Bexarotene
- Bexarotene (Oral)
- Blenrep
- Brexucabtagene autoleucel
- Breyanzi
- Calaspargase pegol
- Calaspargase pegol-mknl
- Camptosar
- Carvykti
- Ciltacabtagene autoleucel
- Danyelza
- Dinutuximab
- Elahere
- Elotuzumab
- Elzonris
- Empliciti
- Enasidenib
- Enfortumab vedotin
- Enfortumab vedotin-ejfv
- Erwinaze
- Hexalen
- Hycamtin (Topotecan Intravenous)
- Hycamtin (Topotecan Oral)
- Hycamtin oral/injection
- Idecabtagene vicleucel
- Idhifa
- Imlygic
- Inotuzumab ozogamicin
- Irinotecan
- Irinotecan liposomal
- Irinotecan liposome
- Ivosidenib
- Kimmtrak
- Krazati
- Kymriah
- Lartruvo
- Levamisole
- Lisocabtagene maraleucel
- Loncastuximab tesirine
- Loncastuximab tesirine-lpyl
- Lumakras
- Lumoxiti
- Lunsumio
- Lysodren
- Matulane
- Mirvetuximab soravtansine
- Mirvetuximab soravtansine-gynx
- Mitotane
- Mogamulizumab
- Mogamulizumab-kpkc
- Mosunetuzumab
- Mosunetuzumab-axgb
- Moxetumomab pasudotox
- Moxetumomab pasudotox-tdfk
- Nadofaragene firadenovec-vncg
- Naxitamab
- Naxitamab-gqgk
- Novaplus Irinotecan Hydrochloride
- Olaratumab
- Olutasidenib
- Omacetaxine
- Oncaspar
- Onivyde
- Onureg
- Padcev
- Pegaspargase
- Polatuzumab vedotin
- Polatuzumab vedotin-piiq
- Polivy
- Poteligeo
- Procarbazine
- Rezlidhia
- Rozanolixizumab-noli
- Rybrevant
- Rylaze
- Rystiggo
- Sacituzumab govitecan
- Sacituzumab govitecan-hziy
- Selinexor
- Sotorasib
- Synribo
- Tagraxofusp
- Tagraxofusp-erzs
- Talimogene laherparepvec
- Talquetamab
- Talquetamab-tgvs
- Talvey
- Targretin
- Targretin (Bexarotene Oral)
- Tazemetostat
- Tazverik
- Tebentafusp
- Tebentafusp-tebn
- Tecartus
- Teclistamab
- Teclistamab-cqyv
- Tecvayli
- Theracys
- Tibsovo
- Tice BCG
- Tice BCG Live (for intravesical use)
- Tisagenlecleucel
- Tisotumab vedotin
- Tisotumab vedotin-tftv
- Tivdak
- Topotecan (Intravenous)
- Topotecan (Oral)
- Topotecan oral/injection
- Tretinoin
- Tretinoin (Oral)
- Trisenox
- Trodelvy
- Unituxin
- Venclexta
- Venetoclax
- Verteporfin
- Vesanoid
- Vidaza
- Visudyne
- Welireg
- Xpovio
- Xpovio 40 mg once-weekly
- Xpovio 40 mg twice-weekly
- Xpovio 60 mg twice-weekly
- Xpovio 80 mg twice-weekly
- Yescarta
- Yonsa
- Yonsa (Abiraterone Oral)
- Yonsa (Abiraterone, micronized Oral)
- Zynlonta
- Zytiga
How to use Xpovio 40 mg twice-weekly
Your doctor will perform tests to make sure Xpovio 40 mg twice-weekly is the right treatment for you.
Follow all directions on your prescription label and read all medication guides or instruction sheets. Your doctor may occasionally change your dose. Use the medicine exactly as directed.
Xpovio 40 mg twice-weekly is usually taken only on specific days, once or twice per week. Follow your doctor's instructions very carefully about when and how to take this medicine with dexamethasone and/or bortezomib.
Your doctor will determine how long to treat you with Xpovio 40 mg twice-weekly and dexamethasone.
Take Xpovio 40 mg twice-weekly with a full glass of water. Swallow the tablet whole and do not crush, chew, or break it.
If you vomit shortly after taking Xpovio 40 mg twice-weekly, do not take another dose. Take your next dose as scheduled.
You may be given other medications to help prevent nausea, vomiting, or infections. Keep taking these medicines for as long as your doctor has prescribed.
You may get infections more easily, even serious or fatal infections. You will need frequent medical tests. You may need a transfusion if your blood platelets get too low.
Your blood sodium levels will need to be tested. If the levels get too low, your doctor may prescribe salt tablets or intravenous (IV) fluids to keep you from getting dehydrated.
Drink plenty of liquids to prevent dehydration, and eat enough calories to prevent weight loss.
Xpovio 40 mg twice-weekly can affect your appetite or ability to eat. You will be weighed before and during treatment to make sure you are not losing weight while taking this medicine.
Store at room temperature away from moisture and heat. Keep each Xpovio 40 mg twice-weekly tablet in the blister pack until you are ready to take your dose.
Warnings
You may get infections more easily, even serious or fatal infections. Call your doctor if you have a fever, chills, flu symptoms, cough, mouth ulcers, or trouble breathing,
Xpovio 40 mg twice-weekly can also cause low platelet counts in your blood. Tell your doctor right away if you have unusual bruising or bleeding.
What other drugs will affect Xpovio 40 mg twice-weekly
Other drugs may affect Xpovio 40 mg twice-weekly, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all other medicines you use.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions